Michael Christian Dobelbower MD
Professor, Radiation Oncology, University of Alabama School of Medicine
Join to View Full Profile
2145 Bonner WayBirmingham, AL 35243
Phone+1 205-934-9999
Fax+1 205-978-8310
Dr. Dobelbower is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Dobelbower is a radiation oncologist based in Birmingham, AL, with a focus on prostate cancer, stereotactic radiosurgery, and tumor imaging. He completed his residency in Radiation Oncology at the University of Alabama Medical Center and an internship at Mercy St Vincent Medical Center. Dr. Dobelbower has authored publications on adaptive radiation therapy, radiosurgery, and AI in oncology, with several of his works being cited multiple times. He has participated in clinical trials related to stereotactic body radiotherapy and hormone therapy for cancer treatment. He has received CMS Meaningful Use Stage 1 and 2 Certifications multiple times for his use of healthcare technology.
Education & Training
University of Alabama Medical CenterResidency, Radiation Oncology, 2003 - 2007
Mercy St Vincent Medical Center/Mercy Health PartnersInternship, Transitional Year, 2002 - 2003
The University of Toledo College of MedicineClass of 2002
Certifications & Licensure
FL State Medical License 2023 - Present
AL State Medical License 2003 - 2026
OH State Medical License 2002 - 2003
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification PowerChart (CQM), Cerner Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification HealtheLife and PowerChart, Cerner Corporation, 2012, 2014, 2016-2017
Clinical Trials
- Dose Escalation/De-escalation Study of Pre-operative Stereotactic Radiosurgery for Brain Metastases(RAD 1002) Start of enrollment: 2010 Oct 01
- Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
- Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203) Start of enrollment: 2013 Feb 01
Publications & Presentations
PubMed
- Brief Report: Mature Outcomes of 61.2 Gy Concomitant Boost Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: CALGB 30610 (Alliance) / RTOG 0538.Jeffrey A Bogart, Xiaofei Wang, Gregory Masters, Ritsuko Komaki, Laurie E Gaspar
International Journal of Radiation Oncology, Biology, Physics. 2026-05-03 - Comparison of 3 vs 5 Fraction Single Isocenter Radiosurgery for Brain Metastases.Luke A Moradi, Richard A Popple, Roman L Travis, Samuel R Marcrom, Kristen O Riley
Advances in Radiation Oncology. 2026-04-01 - CBCT-Guided Online Adaptive Radiation Therapy for Accelerated Partial Breast Irradiation: A Single-Institution Experience.Claudia Warden, Kayla Steed, Whitney Hotsinpiller, Joel Pogue, Joseph Harms
Clinical Breast Cancer. 2026-02-01
Authored Content
- Stereotactic Radiosurgery for Prostate Cancer Following Magnetic Resonance Imaging Directed Biopsy: A Multidisciplinary Approach with Case ExamplesApril 2018
- Stereotactic Radiosurgery for Prostate Cancer Following Magnetic Resonance Imaging Directed Biopsy: A Multidisciplinary Approach with Case ExamplesApril 2018
Press Mentions
Team of UAB Doctors Performs New Procedure for Rare GI MelanomaMarch 30th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
